<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">research-focus</journal-id>
      <journal-title-group>
        <journal-title>Research Focus International Scientific Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Research Focus</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2181-3833</issn>
      <publisher>
        <publisher-name>Ilm-fan va innovatsiyalar akademiyasi</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.66073/researchfocus.v3i11.1191</article-id>
      <article-id pub-id-type="other" assigning-authority="relibrary.uz">REL-A-012682</article-id>
      <article-categories>
        <subj-group subj-group-type="oak">
          <subject>14.00.00</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">CHRONIC KIDNEY DISEASE AND THE STATE OF THE CARDIOVASCULAR SYSTEM</article-title>
        <trans-title-group xml:lang="ru">
          <trans-title>ХРОНИЧЕСКАЯ БОЛЕЗНЬ ПОЧЕК И СОСТОЯНИЕ СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ</trans-title>
        </trans-title-group>
        <trans-title-group xml:lang="uz">
          <trans-title>SURUNKALI BUYRAK KASALLIGI VA YURAK-QON TOMIR TIZIMINING HOLATI</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author">
          <string-name>Tairova Z.K.</string-name>
          <aff>Samarkand State Medical University, Faculty of Dentistry, 1st year student; Scientific supervisor: Abulqosimova Dildora Asrorovna; Samarkand State Medical University, Department of Social and Humanitarian Sciences, assistant</aff>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Xolbayev A.E.</string-name>
        </contrib>
      </contrib-group>
      <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2024-12-05">
        <day>05</day>
        <month>12</month>
        <year>2024</year>
      </pub-date>
      <pub-date date-type="collection">
        <year>2024</year>
      </pub-date>
      <volume>3</volume>
      <issue>11</issue>
      <fpage>244</fpage>
      <lpage>247</lpage>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0">
          <ali:license_ref>https://creativecommons.org/licenses/by/4.0</ali:license_ref>
          <license-p>This work is licensed under a Creative Commons Attribution 4.0 International License.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://relibrary.uz/REL-A-012682/"/>
      <abstract xml:lang="en">
        <p>Chronic kidney disease (CKD) significantly increases the risk of cardiovascular complications and death. Patients with CKD frequently present with endothelial dysfunction, which plays an important role in the development of cardiovascular complications. This article discusses the development of cardiovascular risk, the consequences of endothelial dysfunction, as well as the importance of early diagnosis and treatment strategies.</p>
      </abstract>
      <trans-abstract xml:lang="ru">
        <p>Хроническая болезнь почек (ХБП) значительно увеличивает риск сердечно-сосудистых осложнений и смерти. У больных ХБП часто наблюдается эндотелиальная дисфункция, которая играет важную роль в развитии сердечно-сосудистых осложнений. В данной статье обсуждаются развитие сердечно-сосудистого риска, последствия эндотелиальной дисфункции, а также важность ранней диагностики и стратегии лечения.</p>
      </trans-abstract>
      <trans-abstract xml:lang="uz">
        <p>Surunkali buyrak kasalligi (SBK) yurak-qon tomir asoratlari va o‘lim xavfini sezilarli darajada oshiradi. SBK bilan og‘rigan bemorlarda ko‘pincha endotelial disfunksiya kuzatiladi, u yurak-qon tomir asoratlari rivojlanishida muhim rol o‘ynaydi. Ushbu maqolada yurak-qon tomir xavfining shakllanishi, endotelial disfunksiya oqibatlari, shuningdek, erta tashxislashning ahamiyati va davolash strategiyalari muhokama qilinadi.</p>
      </trans-abstract>
      <kwd-group xml:lang="en">
        <kwd>chronic kidney disease</kwd>
        <kwd>cardiovascular risk</kwd>
        <kwd>endothelial dysfunction</kwd>
        <kwd>arterial hypertension</kwd>
        <kwd>atherosclerosis</kwd>
      </kwd-group>
      <kwd-group xml:lang="ru">
        <kwd>хроническая болезнь почек</kwd>
        <kwd>сердечно-сосудистый риск</kwd>
        <kwd>эндотелиальная дисфункция</kwd>
        <kwd>артериальная гипертензия</kwd>
      </kwd-group>
      <kwd-group xml:lang="uz">
        <kwd>surunkali buyrak kasalligi</kwd>
        <kwd>yurak-qon tomir xavfi</kwd>
        <kwd>endotelial disfunksiya</kwd>
        <kwd>arterial gipertenziya</kwd>
        <kwd>ateroskleroz</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <ref id="r1">
        <label>1</label>
        <mixed-citation>Böhm, M., et al. (2020). &quot;Endothelial Dysfunction in Chronic Kidney Disease.&quot; Journal of Hypertension, 38(2), 210-220.</mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation>Daniel, B., et al. (2018). &quot;The Association Between Endothelial Dysfunction and Cardiovascular Risk in CKD.&quot; Nephrology Dialysis Transplantation, 33(5), 926-935.</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation>Isakova, T., et al. (2011). &quot;Phosphate and Mortality in Chronic Kidney Disease: A Clinical Perspective.&quot; Clinical Journal of the American Society of Nephrology, 6(4), 817-827.</mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation>KDOQI Clinical Practice Guidelines for Nutrition in Chronic Kidney Disease (2012). American Journal of Kidney Diseases, 59(2), 27-48.</mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation>Levey, A. S., Stevens, L. A., Schmid, C. H., et al. (2017). &quot;A new equation to estimate glomerular filtration rate.&quot; Annals of Internal Medicine, 150(9), 604-612.</mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation>Таирова З. К., Шодикулова Г. З. Шоназарова НХ REVMATOID ARTRIT BILAN KASALLANGAN BEMORLARDA KOMORBID KASALLIKLARNING UCHRASH CHASTOTASI //Журнал кардиореспираторных исследований. – 2022. – Т. 3. – №. 4.</mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation>Sharma, K., et al. (2019). &quot;Inflammation and Cardiovascular Disease in Chronic Kidney Disease.&quot; Cardiovascular Nephrology, 4(2), 57-65.</mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation>Kamolidinovna T. Z., Zikriyaevna S. G. RISK FACTORS AND FEATURES OF CORONARY HEART DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS //JOURNAL OF BIOMEDICINE AND PRACTICE. – 2022. – Т. 7. – №. 6.</mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation>Mora-Fernández, C., Domínguez-Pimentel, V., De Fuentes, M. M., et al. (2014). &quot;Cardiovascular Disease in Chronic Kidney Disease: The Role of Endothelial Dysfunction.&quot; Clinical Journal of the American Society of Nephrology, 9(4), 688-695.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
